Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net (loss) income	$ (70,175,000)	$ 34,236,000
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	7,946,000	1,055,000
Provision for credit losses	730,000	0
Amortization on right-of-use asset	392,000	458,000
Stock-based compensation	7,776,000	7,031,000
Loss (gain), net on disposal of property, plant, and equipment	16,000	0
Loss on reserves	639,000	0
Impairment of assets	15,170,000	0
Realized loss (gain) on marketable securities	359,000	(1,706,000)
Amortization of premium and discount of marketable securities, net	(172,000)	3,701,000
Change in fair value of derivative	(237,000)	(620,000)
Change in fair value of common stock warrants liability	2,913,000	(27,438,000)
Change in fair value of earnout liability	2,401,000	(39,137,000)
Deferred tax benefit	375,000	0
Changes in operating assets and liabilities:
Accounts receivable and other receivables	(4,256,000)	(8,130,000)
Inventory	(78,000)	(821,000)
Prepaid expenses and other current assets	962,000	(2,703,000)
Other long-term assets	(4,873,000)	(17,954,000)
Accounts payable	(124,000)	2,819,000
Accrued expenses	(3,082,000)	1,707,000
Operating lease liability	(298,000)	(529,000)
Deferred income	0	1,374,000
Other liabilities, current	(1,507,000)	2,846,000
Other liabilities, long-term	0	(2,636,000)
Net cash used in operating activities	(45,123,000)	(46,447,000)
Cash flows from investing activities
Purchases of property, plant, and equipment	(5,117,000)	(90,113,000)
Purchases of marketable securities	(1,518,398,000)	(3,092,218,000)
Sales of marketable securities	1,456,532,000	3,057,700,000
Maturities of marketable securities	86,441,000	129,081,000
Net cash provided by investing activities	19,458,000	4,450,000
Cash flows from financing activities
Payment of notes payable	(4,793,000)	0
Proceeds from Canadian Government Research and Development Program	8,097,000	0
Proceeds from exercise of stock options	245,000	145,000
Net cash provided by financing activities	3,549,000	145,000
Effects of foreign exchange rate changes on the balance of cash and cash equivalents, and restricted cash held in foreign currencies	3,010,000	(390,000)
Net decrease in cash and cash equivalents, and restricted cash	(19,106,000)	(42,242,000)
Cash and cash equivalents, and restricted cash, beginning of the period	75,502,000	108,348,000
Cash and cash equivalents, and restricted cash, end of the period	56,396,000	66,106,000
Supplemental disclosure of cash flow information
Operating lease right-of-use assets obtained in exchange for lease obligations	0	2,302,000
Stock-based compensation capitalized into property, plant, and equipment	0	2,048,000
Purchases of fixed assets included in accounts payable and accrued expenses	66,000	6,182,000
Cash paid during the period:
Income taxes payment	23,000	129,000
Interest payment	$ 1,708,000	$ 0